T1	Participants 146 170	aspirin-treated patients
T2	Participants 194 234	during and after cardiopulmonary bypass.
T3	Participants 384 408	aspirin-treated patients
T4	Participants 647 702	40 patients undergoing coronary artery bypass grafting.
T5	Participants 746 770	aspirin-treated patients
